X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/02/28/2616693/0/en/Laevoroc-Immunology-Announces-FDA-Orphan-Drug-Designation-Granted-to-LR-09-a-Novel-Metabolic-Immune-Checkpoint-Inhibitor-for-the-Treatment-of-Leukemia-Relapse-after-Allogeneic-Stem.html
https://www.pharmatimes.com/news/laevoroc_announces_promising_purine_nucleoside_phosphorylase_data_1482785